New study tests Fast-Start HIV treatment regimen
NCT ID NCT07357584
Summary
This study is testing how well and how safe a specific three-drug combination pill is for controlling HIV in people who are starting treatment for the first time. It aims to enroll 100 adults who were diagnosed with HIV within the last 30 days. The main goal is to see how many participants have a very low level of virus in their blood after 48 weeks of taking the medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fundacion Huesped
Buenos Aires, C1202ABB, Argentina
-
Fundacion IDEAA -Infectologia de atencion ambulatoria
Ciudad Autonoma de Buenos Aire, Buenos Aires, C1405CKC, Argentina
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.